. (AMRI)
$21.74 - (-)
Market Cap: -
As of 10/13/17 12:00 AM EDT. Market closed.
. (AMRI)
$21.74
- (-)
Market Cap: -
As of 10/13/17 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$21.74
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$21.74
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| FINE MARGALIT | Executive Vice President, API | Aug 31, 2017 | Option Exercise | $21.75 | 23,543 | 512,060 | 0 | Sep 05, 2017, 04:51 PM |
| Ladin Felicia I | SVP, Treasurer & CFO | Aug 31, 2017 | Option Exercise | $21.75 | 63,568 | 1,382,604 | 0 | Sep 05, 2017, 04:50 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 31, 2017 | Option Exercise | $21.75 | 43,655 | 949,496 | 0 | Sep 05, 2017, 04:28 PM |
| OCONNOR KEVIN | Director | Aug 31, 2017 | Option Exercise | $21.75 | 58,275 | 1,267,481 | 0 | Sep 05, 2017, 04:28 PM |
| NAPOLITANO FERNANDO | Director | Aug 31, 2017 | Option Exercise | $21.75 | 3,802 | 82,694 | 0 | Sep 05, 2017, 04:28 PM |
| Deming David H | Director | Aug 31, 2017 | Option Exercise | $21.75 | 6,838 | 148,727 | 0 | Sep 05, 2017, 04:28 PM |
| Gutierrez Fuentes Luis Gerardo | Director | Aug 31, 2017 | Option Exercise | $21.75 | 2,200,000 | 47,850,000 | 0 | Sep 05, 2017, 04:27 PM |
| Gutierrez Fuentes Luis Gerardo | Director | Aug 31, 2017 | Option Exercise | $21.75 | 6,656 | 144,768 | 0 | Sep 05, 2017, 04:27 PM |
| HAGEN KENNETH PAUL | Director | Aug 31, 2017 | Option Exercise | $21.75 | 6,838 | 148,727 | 0 | Sep 05, 2017, 04:27 PM |
| MADDALUNA ANTHONY J | Director | Aug 31, 2017 | Option Exercise | $21.75 | 11,210 | 243,818 | 0 | Sep 05, 2017, 04:27 PM |
| D AMBRA THOMAS E | Director | Aug 31, 2017 | Option Exercise | $21.75 | 2,393,339 | 52,055,123 | 0 | Sep 05, 2017, 04:27 PM |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | Aug 31, 2017 | Option Exercise | $21.75 | 47,477 | 1,032,625 | 0 | Sep 05, 2017, 04:27 PM |
| Svokos George | Chief Operating Officer | Aug 31, 2017 | Option Exercise | $21.75 | 129,150 | 2,809,013 | 0 | Sep 05, 2017, 04:27 PM |
| BOYER MILTON | SVP, Drug Product Manufacturin | Aug 31, 2017 | Option Exercise | $21.75 | 42,109 | 915,871 | 0 | Sep 05, 2017, 04:26 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Aug 31, 2017 | Option Exercise | $21.75 | 66,717 | 1,451,095 | 0 | Sep 05, 2017, 04:26 PM |
| Marth William S | President and CEO | Aug 31, 2017 | Option Exercise | $21.75 | 483,033 | 10,505,968 | 0 | Sep 05, 2017, 04:26 PM |
| FINE MARGALIT | Executive Vice President, API | Jul 15, 2017 | Option Exercise | $21.68 | 1,500 | 32,520 | 11,225 | Jul 18, 2017, 04:05 PM |
| Svokos George | Chief Operating Officer | Jul 05, 2017 | Option Exercise | $16.04 | 1,324 | 21,237 | 123,086 | Jul 06, 2017, 04:06 PM |
| Marth William S | President and CEO | Jul 05, 2017 | Option Exercise | $16.04 | 884 | 14,179 | 521,888 | Jul 06, 2017, 04:06 PM |
| BOYER MILTON | SVP, Drug Product Manufacturin | Jul 05, 2017 | Option Exercise | $16.04 | 1,043 | 16,730 | 38,910 | Jul 06, 2017, 04:06 PM |
| BOYER MILTON | SVP, Drug Product Manufacturin | Jul 01, 2017 | Option Exercise | $21.72 | 1,619 | 35,165 | 37,867 | Jul 05, 2017, 12:00 AM |
| OCONNOR KEVIN | Director | May 25, 2017 | Option Exercise | $14.47 | 5,000 | 72,350 | 58,275 | May 26, 2017, 04:31 PM |
| ROTH ARTHUR J | Director | May 26, 2017 | Option Exercise | $14.47 | 5,000 | 72,350 | 52,575 | May 26, 2017, 04:31 PM |
| RYAN UNA S | Director | May 10, 2017 | Option Exercise | $14.47 | 5,000 | 72,350 | 51,845 | May 11, 2017, 04:05 PM |
| BOYER MILTON | SVP, Drug Product Manufacturin | Mar 02, 2017 | Option Exercise | $14.52 | 277 | 4,022 | 39,486 | Mar 06, 2017, 04:11 PM |
| Ladin Felicia I | SVP, Treasurer & CFO | Mar 02, 2017 | Option Exercise | $14.52 | 361 | 5,242 | 58,575 | Mar 06, 2017, 04:10 PM |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | Mar 02, 2017 | Option Exercise | $14.52 | 271 | 3,935 | 45,230 | Mar 06, 2017, 04:10 PM |
| Svokos George | Chief Operating Officer | Mar 02, 2017 | Option Exercise | $14.52 | 361 | 5,242 | 121,762 | Mar 06, 2017, 04:09 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Mar 02, 2017 | Option Exercise | $14.52 | 432 | 6,273 | 61,995 | Mar 06, 2017, 04:08 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 02, 2017 | Option Exercise | $14.52 | 350 | 5,082 | 40,517 | Mar 06, 2017, 04:07 PM |
| Ladin Felicia I | SVP, Treasurer & CFO | Feb 17, 2017 | Option Exercise | $18.71 | 2,097 | 39,235 | 58,936 | Feb 21, 2017, 04:53 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Feb 04, 2017 | Option Exercise | $18.52 | 3,541 | 65,579 | 47,868 | Feb 07, 2017, 04:39 PM |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | Feb 04, 2017 | Option Exercise | $18.52 | 2,944 | 54,523 | 39,057 | Feb 07, 2017, 04:38 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Feb 04, 2017 | Option Exercise | $18.52 | 3,443 | 63,764 | 31,560 | Feb 07, 2017, 04:03 PM |
| D AMBRA THOMAS E | Director | Feb 04, 2017 | Option Exercise | $18.52 | 1,034 | 19,150 | 2,474,287 | Feb 07, 2017, 04:03 PM |
| Svokos George | Chief Operating Officer | Feb 04, 2017 | Option Exercise | $18.52 | 3,728 | 69,043 | 103,264 | Feb 07, 2017, 04:03 PM |
| Ladin Felicia I | SVP, Treasurer & CFO | Feb 04, 2017 | Option Exercise | $18.52 | 655 | 12,131 | 44,393 | Feb 07, 2017, 04:02 PM |
| BOYER MILTON | SVP, Drug Product Manufacturin | Feb 04, 2017 | Option Exercise | $18.52 | 339 | 6,278 | 29,102 | Feb 07, 2017, 04:02 PM |
| Marth William S | President and CEO | Feb 04, 2017 | Option Exercise | $18.52 | 43,568 | 806,879 | 475,404 | Feb 07, 2017, 04:02 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jan 31, 2017 | Option Exercise | $18.11 | 1,062 | 19,233 | 34,382 | Feb 01, 2017, 04:08 PM |
| D AMBRA THOMAS E | Director | Jan 31, 2017 | Option Exercise | $18.11 | 2,825 | 51,161 | 2,475,321 | Feb 01, 2017, 04:07 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Jan 31, 2017 | Option Exercise | $18.11 | 1,106 | 20,030 | 50,784 | Feb 01, 2017, 04:07 PM |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | Jan 31, 2017 | Option Exercise | $18.11 | 1,061 | 19,215 | 40,957 | Feb 01, 2017, 04:07 PM |
| Svokos George | Chief Operating Officer | Jan 06, 2017 | Option Exercise | $18.98 | 3,535 | 67,094 | 105,645 | Jan 09, 2017, 04:01 PM |
| Marth William S | President and CEO | Jan 01, 2017 | Option Exercise | $18.63 | 8,425 | 156,958 | 517,030 | Jan 03, 2017, 04:06 PM |
| MADDALUNA ANTHONY J | Director | Dec 02, 2016 | Buy | $16.46 | 1,518 | 24,986 | 7,408 | Dec 05, 2016, 04:14 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Nov 30, 2016 | Option Exercise | $13.20 | 9,000 | 118,800 | 43,913 | Dec 01, 2016, 04:10 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Nov 30, 2016 | Sale | $16.71 | 9,000 | 150,390 | 34,913 | Dec 01, 2016, 04:10 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Nov 16, 2016 | Sale | $17.00 | 6,000 | 102,000 | 51,337 | Nov 17, 2016, 04:12 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Nov 10, 2016 | Sale | $16.79 | 785 | 13,180 | 34,913 | Nov 10, 2016, 04:08 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Nov 02, 2016 | Option Exercise | $15.09 | 465 | 7,017 | 35,698 | Nov 03, 2016, 04:54 PM |
| Svokos George | Chief Operating Officer | Nov 02, 2016 | Option Exercise | $15.09 | 817 | 12,329 | 109,180 | Nov 03, 2016, 04:54 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Nov 02, 2016 | Option Exercise | $15.09 | 409 | 6,172 | 57,337 | Nov 03, 2016, 04:54 PM |
| RYAN UNA S | Director | Oct 05, 2016 | Option Exercise | $16.91 | 3,498 | 59,151 | 43,043 | Oct 06, 2016, 04:30 PM |
| RYAN UNA S | Director | Oct 05, 2016 | Option Exercise | $11.83 | 5,000 | 59,150 | 46,541 | Oct 06, 2016, 04:30 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 09, 2016 | Sale | $15.29 | 1,401 | 21,421 | 36,163 | Aug 10, 2016, 04:03 PM |
| Svokos George | Chief Operating Officer | Jul 05, 2016 | Option Exercise | $11.42 | 1,312 | 14,983 | 109,997 | Jul 07, 2016, 04:07 PM |
| Marth William S | President and CEO | Jul 05, 2016 | Option Exercise | $11.42 | 1,312 | 14,983 | 525,455 | Jul 07, 2016, 04:05 PM |
| MADDALUNA ANTHONY J | Director | Jun 15, 2016 | Option Exercise | $14.82 | 3,036 | 44,994 | 5,890 | Jun 16, 2016, 04:37 PM |
| Deming David H | Director | Jun 15, 2016 | Option Exercise | $14.82 | 3,036 | 44,994 | 3,036 | Jun 16, 2016, 04:37 PM |
| OCONNOR KEVIN | Director | Jun 15, 2016 | Option Exercise | $14.82 | 1,518 | 22,497 | 49,473 | Jun 16, 2016, 04:37 PM |
| HAGEN KENNETH PAUL | Director | Jun 15, 2016 | Option Exercise | $14.82 | 3,036 | 44,994 | 3,036 | Jun 16, 2016, 04:37 PM |
| RYAN UNA S | Director | Jun 15, 2016 | Option Exercise | $14.82 | 4,048 | 59,991 | 41,541 | Jun 16, 2016, 04:36 PM |
| OCONNOR KEVIN | Director | May 31, 2016 | Option Exercise | $10.37 | 5,000 | 51,850 | 52,955 | Jun 01, 2016, 04:18 PM |
| OCONNOR KEVIN | Director | May 31, 2016 | Sale | $14.41 | 5,000 | 72,050 | 47,955 | Jun 01, 2016, 04:18 PM |
| ROTH ARTHUR J | Director | May 31, 2016 | Option Exercise | $14.50 | 3,576 | 51,852 | 43,773 | Jun 01, 2016, 04:17 PM |
| ROTH ARTHUR J | Director | May 31, 2016 | Option Exercise | $10.37 | 5,000 | 51,850 | 47,349 | Jun 01, 2016, 04:17 PM |
| Svokos George | Chief Operating Officer | May 13, 2016 | Buy | $12.82 | 12,500 | 160,250 | 108,685 | May 16, 2016, 04:24 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | May 13, 2016 | Sale | $12.77 | 2,361 | 30,150 | 37,564 | May 16, 2016, 04:24 PM |
| Marth William S | President and CEO | May 16, 2016 | Buy | $12.86 | 12,500 | 160,750 | 524,143 | May 16, 2016, 04:24 PM |
| D AMBRA THOMAS E | Director | Mar 02, 2016 | Option Exercise | $15.33 | 862 | 13,214 | 2,490,846 | Mar 04, 2016, 04:40 PM |
| Ladin Felicia I | SVP, Treasurer & CFO | Mar 02, 2016 | Option Exercise | $15.33 | 351 | 5,381 | 45,048 | Mar 04, 2016, 04:28 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 02, 2016 | Option Exercise | $15.33 | 340 | 5,212 | 39,925 | Mar 04, 2016, 04:28 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Mar 02, 2016 | Option Exercise | $15.33 | 421 | 6,454 | 57,746 | Mar 04, 2016, 04:28 PM |
| Svokos George | Chief Operating Officer | Mar 02, 2016 | Option Exercise | $15.33 | 361 | 5,534 | 96,185 | Mar 04, 2016, 04:28 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Feb 17, 2016 | Option Exercise | $15.37 | 463 | 7,116 | 59,626 | Feb 19, 2016, 04:21 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Feb 17, 2016 | Option Exercise | $15.37 | 451 | 6,932 | 41,515 | Feb 19, 2016, 04:20 PM |
| Ladin Felicia I | CFO | Feb 17, 2016 | Option Exercise | $15.37 | 2,217 | 34,075 | 45,399 | Feb 19, 2016, 04:20 PM |
| Gutierrez Fuentes Luis Gerardo | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 2,854 | Feb 08, 2016, 05:27 PM |
| Ladin Felicia I | CFO | Feb 04, 2016 | Option Exercise | $15.77 | 13,792 | 217,500 | 47,616 | Feb 08, 2016, 05:08 PM |
| Marth William S | President and CEO | Jan 06, 2016 | Option Exercise | $16.79 | 490 | 8,227 | 510,668 | Feb 08, 2016, 05:02 PM |
| Marth William S | President and CEO | Feb 04, 2016 | Option Exercise | $15.77 | 71,338 | 1,125,000 | 510,178 | Feb 08, 2016, 05:02 PM |
| Svokos George | Chief Operating Officer | Feb 04, 2016 | Option Exercise | $15.77 | 18,390 | 290,010 | 95,026 | Feb 08, 2016, 05:02 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Feb 04, 2016 | Option Exercise | $15.77 | 12,682 | 199,995 | 60,089 | Feb 08, 2016, 05:02 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Feb 04, 2016 | Option Exercise | $15.77 | 9,988 | 157,511 | 41,966 | Feb 08, 2016, 05:02 PM |
| RYAN UNA S | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 37,493 | Feb 08, 2016, 04:59 PM |
| Jordan Veronica GH | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 40,595 | Feb 08, 2016, 04:59 PM |
| ROTH ARTHUR J | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 42,349 | Feb 08, 2016, 04:58 PM |
| MADDALUNA ANTHONY J | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 2,854 | Feb 08, 2016, 04:52 PM |
| OCONNOR KEVIN | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 47,955 | Feb 08, 2016, 04:52 PM |
| D AMBRA THOMAS E | Director | Feb 04, 2016 | Option Exercise | $15.77 | 2,854 | 45,008 | 2,513,873 | Feb 08, 2016, 04:52 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Feb 04, 2016 | Option Exercise | $16.16 | 684 | 11,053 | 47,407 | Feb 05, 2016, 04:14 PM |
| Svokos George | Chief Operating Officer | Jan 06, 2016 | Option Exercise | $16.79 | 58 | 974 | 77,232 | Feb 05, 2016, 04:13 PM |
| Svokos George | Chief Operating Officer | Feb 04, 2016 | Option Exercise | $16.16 | 596 | 9,631 | 76,636 | Feb 05, 2016, 04:13 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Feb 04, 2016 | Option Exercise | $16.16 | 664 | 10,730 | 31,978 | Feb 05, 2016, 04:13 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jan 31, 2016 | Option Exercise | $15.97 | 1,058 | 16,896 | 33,171 | Feb 01, 2016, 04:16 PM |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | Jan 31, 2016 | Option Exercise | $15.97 | 1,108 | 17,695 | 48,645 | Feb 01, 2016, 04:16 PM |
| Svokos George | Chief Operating Officer | Jan 06, 2016 | Option Exercise | $18.66 | 3,499 | 65,291 | 77,174 | Jan 07, 2016, 05:21 PM |
| Marth William S | President and CEO | Jan 01, 2016 | Option Exercise | $20.16 | 8,374 | 168,820 | 438,840 | Jan 04, 2016, 04:14 PM |
| D AMBRA THOMAS E | Director | Nov 09, 2015 | Sale | $19.60 | 50,000 | 980,000 | 2,511,019 | Nov 10, 2015, 04:34 PM |
| D AMBRA CONSTANCE M | 10% Owner | Nov 09, 2015 | Sale | $19.60 | 50,000 | 980,000 | 2,365,818 | Nov 10, 2015, 04:33 PM |
| HENDERSON LORI M | SVP, Secretary & Gen Counsel | Nov 02, 2015 | Option Exercise | $19.16 | 5,000 | 95,800 | 49,199 | Nov 04, 2015, 04:33 PM |
| Svokos George | Chief Operating Officer | Nov 02, 2015 | Option Exercise | $19.16 | 10,000 | 191,600 | 80,673 | Nov 04, 2015, 04:33 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Nov 02, 2015 | Option Exercise | $19.16 | 5,000 | 95,800 | 33,700 | Nov 04, 2015, 04:33 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 17, 2015 | Option Exercise | $13.20 | 1,000 | 13,200 | 29,700 | Aug 17, 2015, 04:39 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 17, 2015 | Sale | $20.45 | 1,000 | 20,450 | 28,700 | Aug 17, 2015, 04:39 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 07, 2015 | Option Exercise | $13.20 | 5,000 | 66,000 | 33,700 | Aug 10, 2015, 05:03 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Aug 07, 2015 | Sale | $21.06 | 5,000 | 105,300 | 28,700 | Aug 10, 2015, 05:03 PM |
| Gutierrez Fuentes Luis Gerardo | Director | Jul 16, 2015 | Option Exercise | $19.69 | 2,200,000 | 43,318,001 | 2,200,000 | Jul 20, 2015, 05:03 PM |
| RYAN UNA S | Director | Jun 12, 2015 | Option Exercise | $19.98 | 1,126 | 22,497 | 34,639 | Jun 15, 2015, 04:17 PM |
| OCONNOR KEVIN | Director | Jun 12, 2015 | Option Exercise | $19.98 | 2,252 | 44,995 | 45,101 | Jun 15, 2015, 04:16 PM |
| D AMBRA THOMAS E PHD | Director | Jun 10, 2015 | Sale | $19.77 | 20,000 | 395,400 | 2,561,019 | Jun 11, 2015, 05:34 PM |
| D AMBRA CONSTANCE M | 10% Owner | Jun 10, 2015 | Sale | $19.77 | 20,000 | 395,400 | 2,415,818 | Jun 11, 2015, 05:33 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jun 08, 2015 | Option Exercise | $10.43 | 5,000 | 52,150 | 33,700 | Jun 09, 2015, 04:36 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jun 08, 2015 | Sale | $19.99 | 5,000 | 99,950 | 28,700 | Jun 09, 2015, 04:36 PM |
| Marth William S | President and CEO | Jun 04, 2015 | Buy | $19.98 | 10,000 | 199,800 | 447,214 | Jun 08, 2015, 11:32 AM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jun 04, 2015 | Sale | $19.58 | 787 | 15,409 | 28,700 | Jun 05, 2015, 04:25 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jun 02, 2015 | Option Exercise | $5.25 | 3,750 | 19,688 | 33,237 | Jun 04, 2015, 05:09 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Jun 02, 2015 | Sale | $19.39 | 3,750 | 72,712 | 29,487 | Jun 04, 2015, 05:09 PM |
| CABLE STUART M | 10% Owner | Jun 01, 2015 | Sale | $19.69 | 30,000 | 590,706 | 3,880,983 | Jun 02, 2015, 05:17 PM |
| D AMBRA THOMAS E PHD | Director | May 11, 2015 | Sale | $19.11 | 20,000 | 382,200 | 2,587,684 | May 13, 2015, 04:40 PM |
| D AMBRA CONSTANCE M | 10% Owner | May 11, 2015 | Sale | $19.11 | 20,000 | 382,200 | 2,435,818 | May 13, 2015, 04:39 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | May 08, 2015 | Option Exercise | $10.09 | 14,500 | 146,375 | 38,700 | May 11, 2015, 04:45 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | May 08, 2015 | Sale | $19.27 | 14,500 | 279,450 | 31,200 | May 11, 2015, 04:45 PM |
| CABLE STUART M | 10% Owner | May 01, 2015 | Sale | $17.87 | 30,000 | 536,223 | 3,910,983 | May 05, 2015, 04:15 PM |
| D AMBRA THOMAS E PHD | Director | Apr 10, 2015 | Sale | $18.50 | 20,000 | 370,000 | 2,607,684 | Apr 14, 2015, 04:33 PM |
| D AMBRA CONSTANCE M | 10% Owner | Apr 10, 2015 | Sale | $18.50 | 20,000 | 370,000 | 2,455,818 | Apr 14, 2015, 04:33 PM |
| Marth William S | President and CEO | Apr 07, 2015 | Option Exercise | $4.47 | 22,367 | 99,978 | 437,214 | Apr 08, 2015, 05:16 PM |
| CABLE STUART M | 10% Owner | Apr 01, 2015 | Sale | $17.21 | 30,000 | 516,270 | 3,940,983 | Apr 03, 2015, 04:15 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 17, 2015 | Option Exercise | $8.90 | 3,500 | 31,150 | 34,700 | Mar 19, 2015, 05:46 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 17, 2015 | Sale | $18.53 | 3,500 | 64,855 | 31,200 | Mar 19, 2015, 05:46 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 17, 2015 | Sale | $18.53 | 3,500 | 64,855 | 27,700 | Mar 19, 2015, 04:25 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 13, 2015 | Sale | $18.79 | 441 | 8,286 | 31,200 | Mar 16, 2015, 04:38 PM |
| ROTH ARTHUR J | Director | Mar 12, 2015 | Option Exercise | $11.85 | 5,000 | 59,250 | 44,495 | Mar 13, 2015, 04:30 PM |
| ROTH ARTHUR J | Director | Mar 12, 2015 | Sale | $18.26 | 5,000 | 91,300 | 39,495 | Mar 13, 2015, 04:30 PM |
| OCONNOR KEVIN | Director | Mar 12, 2015 | Option Exercise | $11.85 | 5,000 | 59,250 | 47,849 | Mar 13, 2015, 04:29 PM |
| OCONNOR KEVIN | Director | Mar 12, 2015 | Sale | $18.22 | 5,000 | 91,100 | 42,849 | Mar 13, 2015, 04:29 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 11, 2015 | Sale | $18.30 | 721 | 13,194 | 31,641 | Mar 12, 2015, 04:23 PM |
| D AMBRA CONSTANCE M | 10% Owner | Mar 10, 2015 | Sale | $17.65 | 20,000 | 353,000 | 2,475,818 | Mar 11, 2015, 04:42 PM |
| D AMBRA THOMAS E PHD | Director | Mar 10, 2015 | Sale | $17.65 | 20,000 | 353,000 | 2,627,684 | Mar 11, 2015, 04:41 PM |
| Svokos George | Chief Commercial Officer | Mar 10, 2015 | Buy | $17.72 | 10,000 | 177,200 | 70,673 | Mar 11, 2015, 04:39 PM |
| Marth William S | President and CEO | Mar 05, 2015 | Buy | $17.70 | 20,000 | 354,000 | 414,847 | Mar 06, 2015, 04:44 PM |
| Marth William S | President and CEO | Jan 22, 2015 | Option Exercise | $13.84 | 940 | 13,010 | 394,847 | Mar 04, 2015, 05:25 PM |
| Marth William S | President and CEO | Mar 02, 2015 | Option Exercise | $17.05 | 58,651 | 1,000,000 | 393,907 | Mar 04, 2015, 05:25 PM |
| RYAN UNA S | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 33,513 | Mar 04, 2015, 05:25 PM |
| ROTH ARTHUR J | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 39,495 | Mar 04, 2015, 05:24 PM |
| Jordan Veronica GH | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 37,741 | Mar 04, 2015, 05:24 PM |
| LEUNG GABRIEL | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 31,316 | Mar 04, 2015, 05:23 PM |
| OCONNOR KEVIN | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 42,849 | Mar 04, 2015, 05:22 PM |
| Svokos George | Chief Commercial Officer | Mar 02, 2015 | Option Exercise | $17.05 | 8,824 | 150,449 | 60,673 | Mar 04, 2015, 05:22 PM |
| Ladin Felicia I | SVP & Treasurer | Mar 02, 2015 | Option Exercise | $17.05 | 8,824 | 150,449 | 33,824 | Mar 04, 2015, 05:21 PM |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | Mar 02, 2015 | Option Exercise | $17.05 | 7,530 | 128,386 | 32,621 | Mar 04, 2015, 05:20 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Mar 02, 2015 | Option Exercise | $17.05 | 10,588 | 180,525 | 46,134 | Mar 04, 2015, 05:17 PM |
| D AMBRA THOMAS E PHD | Director | Mar 02, 2015 | Option Exercise | $17.05 | 2,639 | 44,995 | 2,647,684 | Mar 04, 2015, 05:14 PM |
| CABLE STUART M | 10% Owner | Mar 02, 2015 | Sale | $16.39 | 30,000 | 491,736 | 3,970,983 | Mar 03, 2015, 04:15 PM |
| Nolan Michael M | CFO | Feb 25, 2015 | Option Exercise | $3.43 | 5,000 | 17,150 | 73,318 | Feb 27, 2015, 04:45 PM |
| Nolan Michael M | CFO | Feb 25, 2015 | Sale | $16.17 | 5,000 | 80,850 | 68,318 | Feb 27, 2015, 04:45 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Feb 23, 2015 | Option Exercise | $5.99 | 3,750 | 22,462 | 28,841 | Feb 25, 2015, 04:52 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Feb 23, 2015 | Sale | $16.22 | 3,750 | 60,825 | 25,091 | Feb 25, 2015, 04:52 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Feb 18, 2015 | Option Exercise | $2.93 | 5,000 | 14,650 | 28,841 | Feb 20, 2015, 04:42 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Feb 18, 2015 | Sale | $16.54 | 6,623 | 109,572 | 25,091 | Feb 20, 2015, 04:42 PM |
| Ladin Felicia I | SVP & Treasurer | Feb 17, 2015 | Option Exercise | $16.70 | 25,000 | 417,500 | 25,000 | Feb 19, 2015, 05:05 PM |
| D AMBRA CONSTANCE M | 10% Owner | Feb 10, 2015 | Sale | $16.91 | 20,000 | 338,200 | 2,495,818 | Feb 12, 2015, 04:41 PM |
| D AMBRA THOMAS E PHD | Director | Feb 10, 2015 | Sale | $16.91 | 20,000 | 338,200 | 2,651,712 | Feb 12, 2015, 04:41 PM |
| Svokos George | SVP Sales & GM of API | Jan 22, 2015 | Option Exercise | $13.84 | 1,445 | 19,999 | 51,849 | Feb 06, 2015, 04:42 PM |
| Luther Michael A | Senior VP, Discovery Services | Jan 22, 2015 | Option Exercise | $13.84 | 1,184 | 16,387 | 32,455 | Feb 06, 2015, 04:41 PM |
| CABLE STUART M | 10% Owner | Feb 02, 2015 | Sale | $16.32 | 30,000 | 489,738 | 4,000,983 | Feb 03, 2015, 04:15 PM |
| D AMBRA CONSTANCE M | 10% Owner | Jan 12, 2015 | Sale | $16.45 | 20,000 | 329,000 | 2,515,818 | Jan 13, 2015, 05:01 PM |
| D AMBRA THOMAS E PHD | Director | Jan 12, 2015 | Sale | $16.45 | 20,000 | 329,000 | 2,678,379 | Jan 13, 2015, 05:00 PM |
| Svokos George | SVP Sales & GM of API | Jan 06, 2015 | Option Exercise | $14.84 | 3,584 | 53,187 | 51,000 | Jan 08, 2015, 04:24 PM |
| CABLE STUART M | 10% Owner | Jan 07, 2015 | Sale | $16.00 | 7,694 | 123,105 | 4,023,289 | Jan 08, 2015, 04:15 PM |
| Marth William S | President and CEO | Jan 01, 2015 | Option Exercise | $16.10 | 8,443 | 135,932 | 335,256 | Jan 05, 2015, 04:45 PM |
| CABLE STUART M | 10% Owner | Jan 05, 2015 | Sale | $16.21 | 22,306 | 361,649 | 4,030,983 | Jan 05, 2015, 04:15 PM |
| D AMBRA THOMAS E PHD | Director | Dec 10, 2014 | Sale | $16.24 | 20,000 | 324,800 | 2,698,379 | Dec 11, 2014, 04:56 PM |
| D AMBRA CONSTANCE M | 10% Owner | Dec 10, 2014 | Sale | $16.24 | 20,000 | 324,800 | 2,535,818 | Dec 11, 2014, 04:56 PM |
| CABLE STUART M | 10% Owner | Dec 05, 2014 | Sale | $16.00 | 13,307 | 212,936 | 4,053,289 | Dec 08, 2014, 04:15 PM |
| CABLE STUART M | 10% Owner | Dec 04, 2014 | Sale | $16.00 | 10,391 | 166,262 | 4,066,596 | Dec 05, 2014, 04:15 PM |
| CABLE STUART M | 10% Owner | Dec 03, 2014 | Sale | $16.00 | 6,302 | 100,845 | 4,076,987 | Dec 05, 2014, 04:15 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Nov 14, 2014 | Option Exercise | $8.31 | 10,500 | 87,255 | 41,433 | Nov 18, 2014, 04:37 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Nov 14, 2014 | Sale | $16.06 | 10,500 | 168,630 | 30,933 | Nov 18, 2014, 04:37 PM |
| D AMBRA CONSTANCE M | 10% Owner | Nov 10, 2014 | Sale | $17.07 | 20,000 | 341,400 | 2,559,318 | Nov 12, 2014, 04:49 PM |
| D AMBRA THOMAS E PHD | Director | Nov 10, 2014 | Sale | $17.07 | 20,000 | 341,400 | 2,721,879 | Nov 12, 2014, 04:48 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Nov 10, 2014 | Option Exercise | $5.99 | 7,500 | 44,925 | 38,433 | Nov 12, 2014, 04:44 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Nov 10, 2014 | Sale | $17.03 | 7,500 | 127,725 | 30,933 | Nov 12, 2014, 04:44 PM |
| Marth William S | President and CEO | Nov 10, 2014 | Buy | $17.01 | 30,000 | 510,300 | 343,699 | Nov 10, 2014, 04:50 PM |
| CABLE STUART M | 10% Owner | Nov 03, 2014 | Sale | $23.00 | 30,000 | 689,949 | 4,083,289 | Nov 05, 2014, 04:15 PM |
| Luther Michael A | Senior VP. Discovery Services | Jul 16, 2014 | Option Exercise | $8.64 | 995 | 8,597 | 33,495 | Oct 30, 2014, 05:41 PM |
| Luther Michael A | Senior VP. Discovery Services | Oct 28, 2014 | Option Exercise | $22.73 | 1,630 | 37,050 | 31,865 | Oct 30, 2014, 05:41 PM |
| D AMBRA THOMAS E PHD | Director | Oct 10, 2014 | Sale | $21.62 | 20,000 | 432,400 | 2,741,879 | Oct 14, 2014, 04:35 PM |
| D AMBRA CONSTANCE M | 10% Owner | Oct 10, 2014 | Sale | $21.62 | 20,000 | 432,400 | 2,579,318 | Oct 14, 2014, 04:35 PM |
| CABLE STUART M | 10% Owner | Oct 01, 2014 | Sale | $21.61 | 30,000 | 648,186 | 4,113,289 | Oct 02, 2014, 04:19 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Oct 01, 2014 | Sale | $21.48 | 1,000 | 21,480 | 41,063 | Oct 01, 2014, 04:22 PM |
| D AMBRA THOMAS E PHD | Director | Sep 10, 2014 | Sale | $20.12 | 20,000 | 402,400 | 2,761,879 | Sep 12, 2014, 04:24 PM |
| D AMBRA CONSTANCE M | 10% Owner | Sep 10, 2014 | Sale | $20.12 | 20,000 | 402,400 | 2,599,318 | Sep 12, 2014, 04:24 PM |
| CABLE STUART M | 10% Owner | Sep 02, 2014 | Sale | $19.30 | 30,000 | 579,003 | 4,143,289 | Sep 04, 2014, 04:16 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Sep 02, 2014 | Sale | $19.56 | 2,500 | 48,900 | 42,063 | Sep 03, 2014, 04:33 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Aug 28, 2014 | Option Exercise | $5.25 | 1,250 | 6,563 | 32,183 | Sep 02, 2014, 04:43 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Aug 28, 2014 | Sale | $19.74 | 1,250 | 24,675 | 30,933 | Sep 02, 2014, 04:43 PM |
| Nolan Michael M | SVP, CFO and Treasurer | Aug 14, 2014 | Option Exercise | $3.43 | 10,000 | 34,300 | 86,093 | Aug 14, 2014, 05:00 PM |
| Nolan Michael M | SVP, CFO and Treasurer | Aug 14, 2014 | Sale | $19.76 | 10,000 | 197,600 | 76,093 | Aug 14, 2014, 05:00 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Aug 12, 2014 | Option Exercise | $4.87 | 30,000 | 146,100 | 74,563 | Aug 13, 2014, 05:15 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Aug 12, 2014 | Sale | $19.05 | 30,000 | 571,500 | 44,563 | Aug 13, 2014, 05:15 PM |
| D AMBRA CONSTANCE M | 10% Owner | Aug 11, 2014 | Sale | $18.99 | 20,000 | 379,800 | 2,639,318 | Aug 13, 2014, 05:10 PM |
| D AMBRA THOMAS E PHD | Director | Aug 11, 2014 | Sale | $18.99 | 20,000 | 379,800 | 2,801,879 | Aug 13, 2014, 05:09 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Aug 08, 2014 | Option Exercise | $5.25 | 10,000 | 52,500 | 40,933 | Aug 12, 2014, 01:51 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Aug 08, 2014 | Sale | $18.99 | 10,797 | 205,035 | 30,933 | Aug 12, 2014, 01:51 PM |
| CABLE STUART M | 10% Owner | Aug 01, 2014 | Sale | $18.69 | 30,000 | 560,634 | 4,173,289 | Aug 04, 2014, 04:15 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Aug 01, 2014 | Sale | $18.56 | 2,500 | 46,400 | 44,563 | Aug 01, 2014, 03:02 PM |
| D AMBRA CONSTANCE M | 10% Owner | Jul 10, 2014 | Sale | $20.94 | 20,000 | 418,800 | 2,659,318 | Jul 14, 2014, 05:11 PM |
| D AMBRA THOMAS E PHD | Director | Jul 10, 2014 | Sale | $20.94 | 20,000 | 418,800 | 2,821,879 | Jul 14, 2014, 05:09 PM |
| CABLE STUART M | 10% Owner | Jul 01, 2014 | Sale | $21.00 | 30,000 | 629,970 | 4,203,289 | Jul 02, 2014, 04:17 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Jul 01, 2014 | Sale | $20.62 | 2,500 | 51,550 | 47,063 | Jul 02, 2014, 04:07 PM |
| Jordan Veronica GH | Director | Jun 04, 2014 | Option Exercise | $17.16 | 1,165 | 19,991 | 35,102 | Jun 06, 2014, 01:31 PM |
| CABLE STUART M | 10% Owner | Jun 02, 2014 | Sale | $16.40 | 30,000 | 492,000 | 4,233,289 | Jun 04, 2014, 05:00 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Jun 03, 2014 | Option Exercise | $2.93 | 2,500 | 7,325 | 34,230 | Jun 04, 2014, 03:43 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | Jun 03, 2014 | Sale | $16.93 | 2,500 | 42,325 | 31,730 | Jun 04, 2014, 03:43 PM |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | Jun 02, 2014 | Sale | $16.32 | 2,500 | 40,800 | 51,497 | Jun 04, 2014, 03:39 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 16, 2014 | Option Exercise | $2.93 | 1,250 | 3,663 | 34,683 | May 20, 2014, 10:43 AM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 16, 2014 | Sale | $15.45 | 1,250 | 19,312 | 33,433 | May 20, 2014, 10:43 AM |
| Svokos George | SVP Sales & GM of API | May 15, 2014 | Buy | $15.60 | 10,000 | 156,000 | 54,584 | May 16, 2014, 09:34 AM |
| Marth William S | President and CEO | May 12, 2014 | Buy | $15.40 | 30,000 | 462,000 | 313,699 | May 13, 2014, 04:13 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 12, 2014 | Option Exercise | $2.93 | 2,500 | 7,325 | 35,933 | May 13, 2014, 04:13 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 09, 2014 | Option Exercise | $2.93 | 2,500 | 7,325 | 35,933 | May 13, 2014, 04:13 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 09, 2014 | Sale | $14.80 | 3,397 | 50,276 | 33,433 | May 13, 2014, 04:13 PM |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | May 12, 2014 | Sale | $15.27 | 2,500 | 38,175 | 33,433 | May 13, 2014, 04:13 PM |
| CABLE STUART M | 10% Owner | May 01, 2014 | Sale | $15.98 | 90,000 | 1,438,200 | 4,263,289 | May 05, 2014, 04:16 PM |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | May 01, 2014 | Sale | $15.73 | 2,500 | 39,325 | 53,997 | May 01, 2014, 05:23 PM |
| CABLE STUART M | 10% Owner | Apr 01, 2014 | Sale | $18.52 | 30,000 | 555,600 | 4,293,289 | Apr 02, 2014, 07:30 PM |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | Apr 01, 2014 | Sale | $18.74 | 2,500 | 46,850 | 56,497 | Apr 02, 2014, 11:03 AM |
| CABLE STUART M | 10% Owner | Mar 03, 2014 | Sale | $15.42 | 30,000 | 462,600 | 4,323,289 | Mar 05, 2014, 04:11 PM |
| ROTH ARTHUR J | Director | Feb 27, 2014 | Option Exercise | $12.85 | 5,000 | 64,250 | 41,856 | Feb 28, 2014, 11:32 AM |
| ROTH ARTHUR J | Director | Feb 27, 2014 | Sale | $15.95 | 5,000 | 79,750 | 36,856 | Feb 28, 2014, 11:32 AM |
| OCONNOR KEVIN | Director | Feb 27, 2014 | Option Exercise | $12.85 | 5,000 | 64,250 | 40,210 | Feb 28, 2014, 11:31 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 27, 2014 | Option Exercise | $9.34 | 3,000 | 28,020 | 37,838 | Feb 27, 2014, 05:05 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 27, 2014 | Sale | $15.73 | 3,000 | 47,190 | 34,838 | Feb 27, 2014, 05:05 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 25, 2014 | Option Exercise | $2.93 | 2,500 | 7,325 | 37,338 | Feb 25, 2014, 03:23 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 25, 2014 | Sale | $15.19 | 2,500 | 37,975 | 34,838 | Feb 25, 2014, 03:23 PM |
| Nolan Michael M | VP, CFO and Treasurer | Feb 24, 2014 | Option Exercise | $3.43 | 15,000 | 51,450 | 91,093 | Feb 25, 2014, 03:22 PM |
| Nolan Michael M | VP, CFO and Treasurer | Feb 24, 2014 | Sale | $15.00 | 15,000 | 225,000 | 76,093 | Feb 25, 2014, 03:22 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 21, 2014 | Sale | $14.87 | 1,500 | 22,305 | 34,838 | Feb 24, 2014, 11:57 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 19, 2014 | Sale | $13.37 | 1,500 | 20,055 | 36,338 | Feb 19, 2014, 04:14 PM |
| CABLE STUART M | 10% Owner | Feb 13, 2014 | Sale | $12.00 | 30,000 | 360,000 | 4,353,289 | Feb 14, 2014, 05:30 PM |
| Svokos George | Sr. VP Sales & GM of API | Feb 04, 2014 | Option Exercise | $10.43 | 14,584 | 152,111 | 44,584 | Feb 06, 2014, 04:57 PM |
| Luther Michael A | Senior VP, Discovery Services | Feb 04, 2014 | Option Exercise | $10.43 | 12,500 | 130,375 | 32,500 | Feb 06, 2014, 04:57 PM |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | Feb 04, 2014 | Option Exercise | $10.43 | 14,584 | 152,111 | 60,035 | Feb 06, 2014, 04:56 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 04, 2014 | Option Exercise | $10.43 | 12,500 | 130,375 | 38,876 | Feb 06, 2014, 04:56 PM |
| Nolan Michael M | VP, CFO and Treasurer | Feb 04, 2014 | Option Exercise | $10.43 | 16,666 | 173,826 | 76,093 | Feb 06, 2014, 04:56 PM |
| Marth William S | President and CEO | Feb 04, 2014 | Option Exercise | $10.50 | 95,238 | 999,999 | 283,699 | Feb 06, 2014, 04:56 PM |
| RYAN UNA S | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 30,874 | Feb 06, 2014, 04:55 PM |
| ROTH ARTHUR J | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 36,856 | Feb 06, 2014, 04:55 PM |
| OCONNOR KEVIN | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 35,210 | Feb 06, 2014, 04:55 PM |
| LEUNG GABRIEL | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 28,677 | Feb 06, 2014, 04:54 PM |
| Jordan Veronica GH | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 33,937 | Feb 06, 2014, 04:54 PM |
| D AMBRA THOMAS E PHD | Director | Feb 04, 2014 | Option Exercise | $10.43 | 3,356 | 35,003 | 2,848,546 | Feb 06, 2014, 04:53 PM |
| Marth William S | President and CEO | Jan 01, 2014 | Option Exercise | $10.08 | 99,207 | 1,000,007 | 190,366 | Jan 03, 2014, 01:14 PM |
| D AMBRA THOMAS E PHD | Director | Jan 01, 2014 | Option Exercise | $10.08 | 99,207 | 1,000,007 | 2,845,190 | Jan 03, 2014, 01:14 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Dec 04, 2013 | Option Exercise | $2.93 | 2,500 | 7,325 | 29,914 | Dec 04, 2013, 09:17 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Dec 04, 2013 | Sale | $10.93 | 2,500 | 27,325 | 27,414 | Dec 04, 2013, 09:17 PM |
| CABLE STUART M | 10% Owner | Dec 02, 2013 | Sale | $12.00 | 1,900 | 22,800 | 4,383,289 | Dec 04, 2013, 04:06 PM |
| Marth William S | Director | Dec 03, 2013 | Buy | $10.75 | 30,000 | 322,500 | 91,159 | Dec 04, 2013, 08:47 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Nov 22, 2013 | Sale | $11.55 | 2,300 | 26,565 | 27,414 | Nov 22, 2013, 02:34 PM |
| Marth William S | Director | Nov 22, 2013 | Buy | $11.57 | 20,000 | 231,400 | 61,159 | Nov 22, 2013, 02:33 PM |
| CABLE STUART M | 10% Owner | Nov 01, 2013 | Sale | $13.06 | 30,000 | 391,800 | 4,385,189 | Nov 05, 2013, 04:06 PM |
| CABLE STUART M | 10% Owner | Oct 01, 2013 | Sale | $12.85 | 30,000 | 385,500 | 4,415,189 | Oct 03, 2013, 04:36 PM |
| CABLE STUART M | 10% Owner | Sep 13, 2013 | Sale | $12.00 | 30,000 | 360,000 | 4,445,189 | Sep 17, 2013, 04:05 PM |
| CABLE STUART M | 10% Owner | Aug 01, 2013 | Sale | $12.53 | 30,000 | 375,900 | 4,475,189 | Aug 02, 2013, 04:16 PM |
| CABLE STUART M | 10% Owner | Jul 01, 2013 | Sale | $12.47 | 30,000 | 374,100 | 4,505,189 | Jul 02, 2013, 04:11 PM |
| CABLE STUART M | 10% Owner | Jun 12, 2013 | Sale | $12.00 | 30,000 | 360,000 | 4,535,189 | Jun 13, 2013, 08:00 PM |
| RYAN UNA S | Director | Jun 05, 2013 | Option Exercise | $10.46 | 1,434 | 15,000 | 27,518 | Jun 06, 2013, 04:27 PM |
| Marth William S | Director | Jun 05, 2013 | Option Exercise | $10.46 | 2,868 | 29,999 | 41,159 | Jun 06, 2013, 04:27 PM |
| ROTH ARTHUR J | Director | Jun 05, 2013 | Option Exercise | $10.46 | 396 | 4,142 | 33,500 | Jun 06, 2013, 04:27 PM |
| OCONNOR KEVIN | Director | Jun 05, 2013 | Option Exercise | $10.46 | 1,434 | 15,000 | 31,854 | Jun 06, 2013, 04:27 PM |
| Jordan Veronica GH | Director | Jun 05, 2013 | Option Exercise | $10.46 | 1,434 | 15,000 | 30,581 | Jun 06, 2013, 04:27 PM |
| Marth William S | Director | Jun 03, 2013 | Buy | $10.23 | 10,000 | 102,300 | 38,291 | Jun 06, 2013, 04:26 PM |
| Marth William S | Director | Jun 03, 2013 | Buy | $10.23 | 10,000 | 102,300 | 38,291 | Jun 04, 2013, 11:49 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | May 29, 2013 | Sale | $11.26 | 800 | 9,008 | 31,780 | May 31, 2013, 08:45 AM |
| Sargent Bruce J | Sr VP, Drug Discovery | May 22, 2013 | Option Exercise | $2.93 | 7,500 | 21,975 | 64,590 | May 23, 2013, 03:09 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | May 22, 2013 | Sale | $10.97 | 7,500 | 82,275 | 57,090 | May 23, 2013, 03:09 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | May 10, 2013 | Sale | $10.40 | 1,200 | 12,480 | 32,580 | May 13, 2013, 01:19 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 19, 2013 | Sale | $9.91 | 258 | 2,557 | 57,090 | Mar 20, 2013, 05:18 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 18, 2013 | Sale | $9.98 | 256 | 2,555 | 57,348 | Mar 20, 2013, 05:18 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Mar 18, 2013 | Sale | $9.98 | 249 | 2,485 | 33,960 | Mar 20, 2013, 05:02 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Mar 19, 2013 | Sale | $9.91 | 180 | 1,784 | 33,780 | Mar 20, 2013, 05:02 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Mar 12, 2013 | Sale | $10.75 | 677 | 7,278 | 34,209 | Mar 14, 2013, 10:30 AM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 13, 2013 | Sale | $10.69 | 852 | 9,108 | 57,604 | Mar 13, 2013, 04:59 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 12, 2013 | Sale | $10.74 | 1,764 | 18,942 | 59,150 | Mar 13, 2013, 04:59 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 11, 2013 | Sale | $10.25 | 3,538 | 36,265 | 60,220 | Mar 13, 2013, 04:59 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Mar 07, 2013 | Sale | $9.56 | 1,000 | 9,560 | 34,886 | Mar 11, 2013, 09:44 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 22, 2013 | Sale | $8.18 | 984 | 8,049 | 35,886 | Feb 26, 2013, 11:28 AM |
| Sargent Bruce J | Sr VP, Drug Discovery | Feb 22, 2013 | Sale | $8.18 | 984 | 8,049 | 63,758 | Feb 26, 2013, 11:28 AM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Feb 19, 2013 | Sale | $7.89 | 1,000 | 7,890 | 36,870 | Feb 21, 2013, 02:14 PM |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | Jan 31, 2013 | Option Exercise | $5.99 | 26,666 | 159,729 | 2,769,850 | Feb 04, 2013, 04:52 PM |
| HENDERSON LORI M | VP, general counsel | Jan 31, 2013 | Option Exercise | $5.99 | 11,666 | 69,879 | 49,440 | Feb 04, 2013, 04:52 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Jan 31, 2013 | Option Exercise | $5.99 | 10,000 | 59,900 | 37,870 | Feb 04, 2013, 04:52 PM |
| Nolan Michael M | VP, CFO and Treasurer | Jan 31, 2013 | Option Exercise | $5.99 | 13,333 | 79,865 | 63,333 | Feb 04, 2013, 04:52 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Jan 31, 2013 | Option Exercise | $5.99 | 10,000 | 59,900 | 64,742 | Feb 04, 2013, 04:51 PM |
| RYAN UNA S | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 26,084 | Feb 04, 2013, 03:39 PM |
| ROTH ARTHUR J | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 33,104 | Feb 04, 2013, 03:38 PM |
| OCONNOR KEVIN | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 30,420 | Feb 04, 2013, 03:38 PM |
| Marth William S | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 28,291 | Feb 04, 2013, 03:38 PM |
| LEUNG GABRIEL | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 25,321 | Feb 04, 2013, 03:37 PM |
| Jordan Veronica GH | Director | Jan 31, 2013 | Option Exercise | $5.99 | 5,843 | 35,000 | 29,147 | Feb 04, 2013, 03:37 PM |
| Marth William S | Director | Dec 03, 2012 | Buy | $5.00 | 10,000 | 50,000 | 22,448 | Dec 04, 2012, 12:24 PM |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | Nov 15, 2012 | Buy | $3.80 | 10,000 | 38,000 | 3,118,184 | Nov 19, 2012, 08:59 PM |
| D AMBRA CONSTANCE M | 10% Owner | Nov 15, 2012 | Buy | $3.80 | 10,000 | 38,000 | 3,071,518 | Nov 19, 2012, 08:56 PM |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | Nov 05, 2012 | Sale | $3.51 | 372 | 1,306 | 27,870 | Nov 06, 2012, 03:55 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Aug 24, 2012 | Sale | $3.22 | 1,000 | 3,220 | 28,242 | Aug 27, 2012, 02:01 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Aug 09, 2012 | Sale | $3.00 | 3,000 | 9,000 | 29,242 | Aug 13, 2012, 12:28 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Jun 05, 2012 | Sale | $2.28 | 504 | 1,149 | 52,012 | Jun 07, 2012, 03:57 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Jun 05, 2012 | Sale | $2.28 | 504 | 1,149 | 33,492 | Jun 07, 2012, 03:56 PM |
| RYAN UNA S | Director | Jun 06, 2012 | Option Exercise | $2.41 | 6,224 | 15,000 | 20,241 | Jun 07, 2012, 03:56 PM |
| ROTH ARTHUR J | Director | Jun 06, 2012 | Option Exercise | $2.41 | 7,261 | 17,499 | 27,261 | Jun 07, 2012, 03:56 PM |
| OCONNOR KEVIN | Director | Jun 06, 2012 | Option Exercise | $2.41 | 6,224 | 15,000 | 24,577 | Jun 07, 2012, 03:55 PM |
| Marth William S | Director | Jun 06, 2012 | Option Exercise | $2.41 | 12,448 | 30,000 | 12,448 | Jun 07, 2012, 03:55 PM |
| LEUNG GABRIEL | Director | Jun 06, 2012 | Option Exercise | $2.41 | 6,224 | 15,000 | 19,478 | Jun 07, 2012, 03:54 PM |
| Jordan Veronica GH | Director | Jun 06, 2012 | Option Exercise | $2.41 | 6,224 | 15,000 | 23,304 | Jun 07, 2012, 03:54 PM |
| RYAN UNA S | Director | May 22, 2012 | Buy | $2.81 | 200 | 562 | 14,017 | May 23, 2012, 11:37 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | May 15, 2012 | Sale | $3.01 | 2,400 | 7,224 | 33,996 | May 16, 2012, 04:07 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 19, 2012 | Sale | $2.76 | 1,160 | 3,204 | 52,803 | Mar 21, 2012, 11:08 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Mar 19, 2012 | Sale | $2.76 | 1,078 | 2,975 | 36,601 | Mar 21, 2012, 11:08 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Mar 06, 2012 | Sale | $2.66 | 91 | 242 | 37,474 | Mar 08, 2012, 09:12 AM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 06, 2012 | Sale | $2.66 | 220 | 585 | 53,676 | Mar 08, 2012, 09:11 AM |
| Sargent Bruce J | Sr VP, Drug Discovery | Feb 17, 2012 | Option Exercise | $2.93 | 10,000 | 29,300 | 53,896 | Feb 22, 2012, 12:01 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Feb 17, 2012 | Option Exercise | $2.93 | 10,000 | 29,300 | 37,565 | Feb 21, 2012, 05:12 PM |
| Frost Mark T | Chief Financial Officer | Feb 17, 2012 | Option Exercise | $2.93 | 13,333 | 39,066 | 76,266 | Feb 21, 2012, 05:12 PM |
| HENDERSON LORI M | VP, general counsel | Feb 17, 2012 | Option Exercise | $2.93 | 11,666 | 34,181 | 39,232 | Feb 21, 2012, 05:12 PM |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | Feb 17, 2012 | Option Exercise | $2.93 | 26,666 | 78,131 | 4,657,900 | Feb 21, 2012, 05:12 PM |
| LEUNG GABRIEL | Director | Dec 07, 2011 | Buy | $2.34 | 4,000 | 9,360 | 13,254 | Dec 07, 2011, 03:28 PM |
| LEUNG GABRIEL | Director | Dec 06, 2011 | Buy | $2.45 | 4,000 | 9,800 | 9,254 | Dec 07, 2011, 03:28 PM |
| HENDERSON LORI M | VP, general counsel | Dec 07, 2011 | Buy | $2.47 | 5,900 | 14,573 | 27,566 | Dec 07, 2011, 02:10 PM |
| Frost Mark T | Chief Financial Officer | Dec 01, 2011 | Buy | $2.26 | 10,000 | 22,600 | 62,933 | Dec 02, 2011, 04:04 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Nov 14, 2011 | Sale | $2.62 | 382 | 1,001 | 27,565 | Nov 14, 2011, 11:49 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Nov 04, 2011 | Sale | $3.11 | 1,139 | 3,542 | 27,947 | Nov 08, 2011, 02:46 PM |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | Jun 02, 2011 | Option Exercise | $5.25 | 26,666 | 139,997 | 4,631,234 | Jun 06, 2011, 04:15 PM |
| Frost Mark T | Chief Financial Officer | Jun 02, 2011 | Option Exercise | $5.25 | 13,333 | 69,998 | 52,933 | Jun 06, 2011, 04:14 PM |
| HENDERSON LORI M | VP, general counsel | Jun 02, 2011 | Option Exercise | $5.25 | 11,666 | 61,247 | 21,666 | Jun 06, 2011, 04:13 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Jun 02, 2011 | Option Exercise | $5.25 | 10,000 | 52,500 | 41,069 | Jun 06, 2011, 04:13 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Jun 02, 2011 | Option Exercise | $5.25 | 10,000 | 52,500 | 29,086 | Jun 06, 2011, 04:13 PM |
| ANDERSON PAUL S | Director | Jun 01, 2011 | Option Exercise | $5.14 | 2,918 | 14,999 | 13,353 | Jun 03, 2011, 11:04 AM |
| Jordan Veronica GH | Director | Jun 01, 2011 | Option Exercise | $5.14 | 2,918 | 14,999 | 17,081 | Jun 03, 2011, 11:04 AM |
| LEUNG GABRIEL | Director | Jun 01, 2011 | Option Exercise | $5.14 | 2,918 | 14,999 | 5,254 | Jun 03, 2011, 11:03 AM |
| OCONNOR KEVIN | Director | Jun 01, 2011 | Option Exercise | $5.14 | 3,891 | 20,000 | 18,353 | Jun 03, 2011, 11:03 AM |
| ROTH ARTHUR J | Director | Jun 01, 2011 | Option Exercise | $5.14 | 2,000 | 10,280 | 20,000 | Jun 03, 2011, 11:03 AM |
| RYAN UNA S | Director | Jun 01, 2011 | Option Exercise | $5.14 | 2,918 | 14,999 | 13,817 | Jun 03, 2011, 11:03 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | May 06, 2011 | Sale | $4.84 | 198 | 958 | 19,086 | May 12, 2011, 04:05 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | May 06, 2011 | Sale | $4.84 | 237 | 1,147 | 31,069 | May 12, 2011, 03:52 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 18, 2011 | Sale | $4.18 | 863 | 3,607 | 31,306 | Mar 28, 2011, 04:11 PM |
| Sargent Bruce J | Sr VP, Drug Discovery | Mar 07, 2011 | Sale | $4.46 | 211 | 941 | 32,169 | Mar 28, 2011, 04:11 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Mar 18, 2011 | Sale | $4.18 | 617 | 2,579 | 19,284 | Mar 28, 2011, 04:11 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Mar 07, 2011 | Sale | $4.46 | 87 | 388 | 19,901 | Mar 28, 2011, 04:11 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Dec 06, 2010 | Sale | $5.20 | 2,000 | 10,400 | 19,988 | Dec 06, 2010, 04:49 PM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Nov 14, 2010 | Sale | $5.77 | 887 | 5,118 | 21,988 | Nov 23, 2010, 11:23 AM |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | Nov 10, 2010 | Sale | $6.09 | 355 | 2,162 | 22,875 | Nov 23, 2010, 11:23 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| FINE MARGALIT | Executive Vice President, API | 08/31/2017 | 512,060 |
| Ladin Felicia I | SVP, Treasurer & CFO | 08/31/2017 | 1,382,604 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/31/2017 | 949,496 |
| OCONNOR KEVIN | Director | 08/31/2017 | 1,267,481 |
| NAPOLITANO FERNANDO | Director | 08/31/2017 | 82,694 |
| Deming David H | Director | 08/31/2017 | 148,727 |
| Gutierrez Fuentes Luis Gerardo | Director | 08/31/2017 | 47,850,000 |
| Gutierrez Fuentes Luis Gerardo | Director | 08/31/2017 | 144,768 |
| HAGEN KENNETH PAUL | Director | 08/31/2017 | 148,727 |
| MADDALUNA ANTHONY J | Director | 08/31/2017 | 243,818 |
| D AMBRA THOMAS E | Director | 08/31/2017 | 52,055,123 |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | 08/31/2017 | 1,032,625 |
| Svokos George | Chief Operating Officer | 08/31/2017 | 2,809,013 |
| BOYER MILTON | SVP, Drug Product Manufacturin | 08/31/2017 | 915,871 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 08/31/2017 | 1,451,095 |
| Marth William S | President and CEO | 08/31/2017 | 10,505,968 |
| FINE MARGALIT | Executive Vice President, API | 07/15/2017 | 32,520 |
| Svokos George | Chief Operating Officer | 07/05/2017 | 21,237 |
| Marth William S | President and CEO | 07/05/2017 | 14,179 |
| BOYER MILTON | SVP, Drug Product Manufacturin | 07/05/2017 | 16,730 |
| BOYER MILTON | SVP, Drug Product Manufacturin | 07/01/2017 | 35,165 |
| OCONNOR KEVIN | Director | 05/25/2017 | 72,350 |
| ROTH ARTHUR J | Director | 05/26/2017 | 72,350 |
| RYAN UNA S | Director | 05/10/2017 | 72,350 |
| BOYER MILTON | SVP, Drug Product Manufacturin | 03/02/2017 | 4,022 |
| Ladin Felicia I | SVP, Treasurer & CFO | 03/02/2017 | 5,242 |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | 03/02/2017 | 3,935 |
| Svokos George | Chief Operating Officer | 03/02/2017 | 5,242 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 03/02/2017 | 6,273 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/02/2017 | 5,082 |
| Ladin Felicia I | SVP, Treasurer & CFO | 02/17/2017 | 39,235 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 02/04/2017 | 65,579 |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | 02/04/2017 | 54,523 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 02/04/2017 | 63,764 |
| D AMBRA THOMAS E | Director | 02/04/2017 | 19,150 |
| Svokos George | Chief Operating Officer | 02/04/2017 | 69,043 |
| Ladin Felicia I | SVP, Treasurer & CFO | 02/04/2017 | 12,131 |
| BOYER MILTON | SVP, Drug Product Manufacturin | 02/04/2017 | 6,278 |
| Marth William S | President and CEO | 02/04/2017 | 806,879 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 01/31/2017 | 19,233 |
| D AMBRA THOMAS E | Director | 01/31/2017 | 51,161 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 01/31/2017 | 20,030 |
| CONWAY CHRISTOPHER M. | SVP, Discovery and Development | 01/31/2017 | 19,215 |
| Svokos George | Chief Operating Officer | 01/06/2017 | 67,094 |
| Marth William S | President and CEO | 01/01/2017 | 156,958 |
| MADDALUNA ANTHONY J | Director | 12/02/2016 | 24,986 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 11/30/2016 | 118,800 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 11/30/2016 | 150,390 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 11/16/2016 | 102,000 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 11/10/2016 | 13,180 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 11/02/2016 | 7,017 |
| Svokos George | Chief Operating Officer | 11/02/2016 | 12,329 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 11/02/2016 | 6,172 |
| RYAN UNA S | Director | 10/05/2016 | 59,151 |
| RYAN UNA S | Director | 10/05/2016 | 59,150 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/09/2016 | 21,421 |
| Svokos George | Chief Operating Officer | 07/05/2016 | 14,983 |
| Marth William S | President and CEO | 07/05/2016 | 14,983 |
| MADDALUNA ANTHONY J | Director | 06/15/2016 | 44,994 |
| Deming David H | Director | 06/15/2016 | 44,994 |
| OCONNOR KEVIN | Director | 06/15/2016 | 22,497 |
| HAGEN KENNETH PAUL | Director | 06/15/2016 | 44,994 |
| RYAN UNA S | Director | 06/15/2016 | 59,991 |
| OCONNOR KEVIN | Director | 05/31/2016 | 51,850 |
| OCONNOR KEVIN | Director | 05/31/2016 | 72,050 |
| ROTH ARTHUR J | Director | 05/31/2016 | 51,852 |
| ROTH ARTHUR J | Director | 05/31/2016 | 51,850 |
| Svokos George | Chief Operating Officer | 05/13/2016 | 160,250 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 05/13/2016 | 30,150 |
| Marth William S | President and CEO | 05/16/2016 | 160,750 |
| D AMBRA THOMAS E | Director | 03/02/2016 | 13,214 |
| Ladin Felicia I | SVP, Treasurer & CFO | 03/02/2016 | 5,381 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/02/2016 | 5,212 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 03/02/2016 | 6,454 |
| Svokos George | Chief Operating Officer | 03/02/2016 | 5,534 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 02/17/2016 | 7,116 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 02/17/2016 | 6,932 |
| Ladin Felicia I | CFO | 02/17/2016 | 34,075 |
| Gutierrez Fuentes Luis Gerardo | Director | 02/04/2016 | 45,008 |
| Ladin Felicia I | CFO | 02/04/2016 | 217,500 |
| Marth William S | President and CEO | 01/06/2016 | 8,227 |
| Marth William S | President and CEO | 02/04/2016 | 1,125,000 |
| Svokos George | Chief Operating Officer | 02/04/2016 | 290,010 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 02/04/2016 | 199,995 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 02/04/2016 | 157,511 |
| RYAN UNA S | Director | 02/04/2016 | 45,008 |
| Jordan Veronica GH | Director | 02/04/2016 | 45,008 |
| ROTH ARTHUR J | Director | 02/04/2016 | 45,008 |
| MADDALUNA ANTHONY J | Director | 02/04/2016 | 45,008 |
| OCONNOR KEVIN | Director | 02/04/2016 | 45,008 |
| D AMBRA THOMAS E | Director | 02/04/2016 | 45,008 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 02/04/2016 | 11,053 |
| Svokos George | Chief Operating Officer | 01/06/2016 | 974 |
| Svokos George | Chief Operating Officer | 02/04/2016 | 9,631 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 02/04/2016 | 10,730 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 01/31/2016 | 16,896 |
| HENDERSON LORI M. | SVP, Secretary & Gen Counsel | 01/31/2016 | 17,695 |
| Svokos George | Chief Operating Officer | 01/06/2016 | 65,291 |
| Marth William S | President and CEO | 01/01/2016 | 168,820 |
| D AMBRA THOMAS E | Director | 11/09/2015 | 980,000 |
| D AMBRA CONSTANCE M | 10% Owner | 11/09/2015 | 980,000 |
| HENDERSON LORI M | SVP, Secretary & Gen Counsel | 11/02/2015 | 95,800 |
| Svokos George | Chief Operating Officer | 11/02/2015 | 191,600 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 11/02/2015 | 95,800 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/17/2015 | 13,200 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/17/2015 | 20,450 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/07/2015 | 66,000 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 08/07/2015 | 105,300 |
| Gutierrez Fuentes Luis Gerardo | Director | 07/16/2015 | 43,318,001 |
| RYAN UNA S | Director | 06/12/2015 | 22,497 |
| OCONNOR KEVIN | Director | 06/12/2015 | 44,995 |
| D AMBRA THOMAS E PHD | Director | 06/10/2015 | 395,400 |
| D AMBRA CONSTANCE M | 10% Owner | 06/10/2015 | 395,400 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 06/08/2015 | 52,150 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 06/08/2015 | 99,950 |
| Marth William S | President and CEO | 06/04/2015 | 199,800 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 06/04/2015 | 15,409 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 06/02/2015 | 19,688 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 06/02/2015 | 72,712 |
| CABLE STUART M | 10% Owner | 06/01/2015 | 590,706 |
| D AMBRA THOMAS E PHD | Director | 05/11/2015 | 382,200 |
| D AMBRA CONSTANCE M | 10% Owner | 05/11/2015 | 382,200 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 05/08/2015 | 146,375 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 05/08/2015 | 279,450 |
| CABLE STUART M | 10% Owner | 05/01/2015 | 536,223 |
| D AMBRA THOMAS E PHD | Director | 04/10/2015 | 370,000 |
| D AMBRA CONSTANCE M | 10% Owner | 04/10/2015 | 370,000 |
| Marth William S | President and CEO | 04/07/2015 | 99,978 |
| CABLE STUART M | 10% Owner | 04/01/2015 | 516,270 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/17/2015 | 31,150 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/17/2015 | 64,855 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/17/2015 | 64,855 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/13/2015 | 8,286 |
| ROTH ARTHUR J | Director | 03/12/2015 | 59,250 |
| ROTH ARTHUR J | Director | 03/12/2015 | 91,300 |
| OCONNOR KEVIN | Director | 03/12/2015 | 59,250 |
| OCONNOR KEVIN | Director | 03/12/2015 | 91,100 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/11/2015 | 13,194 |
| D AMBRA CONSTANCE M | 10% Owner | 03/10/2015 | 353,000 |
| D AMBRA THOMAS E PHD | Director | 03/10/2015 | 353,000 |
| Svokos George | Chief Commercial Officer | 03/10/2015 | 177,200 |
| Marth William S | President and CEO | 03/05/2015 | 354,000 |
| Marth William S | President and CEO | 01/22/2015 | 13,010 |
| Marth William S | President and CEO | 03/02/2015 | 1,000,000 |
| RYAN UNA S | Director | 03/02/2015 | 44,995 |
| ROTH ARTHUR J | Director | 03/02/2015 | 44,995 |
| Jordan Veronica GH | Director | 03/02/2015 | 44,995 |
| LEUNG GABRIEL | Director | 03/02/2015 | 44,995 |
| OCONNOR KEVIN | Director | 03/02/2015 | 44,995 |
| Svokos George | Chief Commercial Officer | 03/02/2015 | 150,449 |
| Ladin Felicia I | SVP & Treasurer | 03/02/2015 | 150,449 |
| Hagen Steven R | SVP Manufacturing & Pharmaceut | 03/02/2015 | 128,386 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 03/02/2015 | 180,525 |
| D AMBRA THOMAS E PHD | Director | 03/02/2015 | 44,995 |
| CABLE STUART M | 10% Owner | 03/02/2015 | 491,736 |
| Nolan Michael M | CFO | 02/25/2015 | 17,150 |
| Nolan Michael M | CFO | 02/25/2015 | 80,850 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 02/23/2015 | 22,462 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 02/23/2015 | 60,825 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 02/18/2015 | 14,650 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 02/18/2015 | 109,572 |
| Ladin Felicia I | SVP & Treasurer | 02/17/2015 | 417,500 |
| D AMBRA CONSTANCE M | 10% Owner | 02/10/2015 | 338,200 |
| D AMBRA THOMAS E PHD | Director | 02/10/2015 | 338,200 |
| Svokos George | SVP Sales & GM of API | 01/22/2015 | 19,999 |
| Luther Michael A | Senior VP, Discovery Services | 01/22/2015 | 16,387 |
| CABLE STUART M | 10% Owner | 02/02/2015 | 489,738 |
| D AMBRA CONSTANCE M | 10% Owner | 01/12/2015 | 329,000 |
| D AMBRA THOMAS E PHD | Director | 01/12/2015 | 329,000 |
| Svokos George | SVP Sales & GM of API | 01/06/2015 | 53,187 |
| CABLE STUART M | 10% Owner | 01/07/2015 | 123,105 |
| Marth William S | President and CEO | 01/01/2015 | 135,932 |
| CABLE STUART M | 10% Owner | 01/05/2015 | 361,649 |
| D AMBRA THOMAS E PHD | Director | 12/10/2014 | 324,800 |
| D AMBRA CONSTANCE M | 10% Owner | 12/10/2014 | 324,800 |
| CABLE STUART M | 10% Owner | 12/05/2014 | 212,936 |
| CABLE STUART M | 10% Owner | 12/04/2014 | 166,262 |
| CABLE STUART M | 10% Owner | 12/03/2014 | 100,845 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 11/14/2014 | 87,255 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 11/14/2014 | 168,630 |
| D AMBRA CONSTANCE M | 10% Owner | 11/10/2014 | 341,400 |
| D AMBRA THOMAS E PHD | Director | 11/10/2014 | 341,400 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 11/10/2014 | 44,925 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 11/10/2014 | 127,725 |
| Marth William S | President and CEO | 11/10/2014 | 510,300 |
| CABLE STUART M | 10% Owner | 11/03/2014 | 689,949 |
| Luther Michael A | Senior VP. Discovery Services | 07/16/2014 | 8,597 |
| Luther Michael A | Senior VP. Discovery Services | 10/28/2014 | 37,050 |
| D AMBRA THOMAS E PHD | Director | 10/10/2014 | 432,400 |
| D AMBRA CONSTANCE M | 10% Owner | 10/10/2014 | 432,400 |
| CABLE STUART M | 10% Owner | 10/01/2014 | 648,186 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 10/01/2014 | 21,480 |
| D AMBRA THOMAS E PHD | Director | 09/10/2014 | 402,400 |
| D AMBRA CONSTANCE M | 10% Owner | 09/10/2014 | 402,400 |
| CABLE STUART M | 10% Owner | 09/02/2014 | 579,003 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 09/02/2014 | 48,900 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 08/28/2014 | 6,563 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 08/28/2014 | 24,675 |
| Nolan Michael M | SVP, CFO and Treasurer | 08/14/2014 | 34,300 |
| Nolan Michael M | SVP, CFO and Treasurer | 08/14/2014 | 197,600 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 08/12/2014 | 146,100 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 08/12/2014 | 571,500 |
| D AMBRA CONSTANCE M | 10% Owner | 08/11/2014 | 379,800 |
| D AMBRA THOMAS E PHD | Director | 08/11/2014 | 379,800 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 08/08/2014 | 52,500 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 08/08/2014 | 205,035 |
| CABLE STUART M | 10% Owner | 08/01/2014 | 560,634 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 08/01/2014 | 46,400 |
| D AMBRA CONSTANCE M | 10% Owner | 07/10/2014 | 418,800 |
| D AMBRA THOMAS E PHD | Director | 07/10/2014 | 418,800 |
| CABLE STUART M | 10% Owner | 07/01/2014 | 629,970 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 07/01/2014 | 51,550 |
| Jordan Veronica GH | Director | 06/04/2014 | 19,991 |
| CABLE STUART M | 10% Owner | 06/02/2014 | 492,000 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 06/03/2014 | 7,325 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 06/03/2014 | 42,325 |
| HENDERSON LORI M | SVP, Secretary & Gen. Counsel | 06/02/2014 | 40,800 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/16/2014 | 3,663 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/16/2014 | 19,312 |
| Svokos George | SVP Sales & GM of API | 05/15/2014 | 156,000 |
| Marth William S | President and CEO | 05/12/2014 | 462,000 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/12/2014 | 7,325 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/09/2014 | 7,325 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/09/2014 | 50,276 |
| Hagen Steven R | SVP Pharmaceutical Dev & Mfg | 05/12/2014 | 38,175 |
| CABLE STUART M | 10% Owner | 05/01/2014 | 1,438,200 |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | 05/01/2014 | 39,325 |
| CABLE STUART M | 10% Owner | 04/01/2014 | 555,600 |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | 04/01/2014 | 46,850 |
| CABLE STUART M | 10% Owner | 03/03/2014 | 462,600 |
| ROTH ARTHUR J | Director | 02/27/2014 | 64,250 |
| ROTH ARTHUR J | Director | 02/27/2014 | 79,750 |
| OCONNOR KEVIN | Director | 02/27/2014 | 64,250 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/27/2014 | 28,020 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/27/2014 | 47,190 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/25/2014 | 7,325 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/25/2014 | 37,975 |
| Nolan Michael M | VP, CFO and Treasurer | 02/24/2014 | 51,450 |
| Nolan Michael M | VP, CFO and Treasurer | 02/24/2014 | 225,000 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/21/2014 | 22,305 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/19/2014 | 20,055 |
| CABLE STUART M | 10% Owner | 02/13/2014 | 360,000 |
| Svokos George | Sr. VP Sales & GM of API | 02/04/2014 | 152,111 |
| Luther Michael A | Senior VP, Discovery Services | 02/04/2014 | 130,375 |
| HENDERSON LORI M | VP, Secretary & Gen. Counsel | 02/04/2014 | 152,111 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/04/2014 | 130,375 |
| Nolan Michael M | VP, CFO and Treasurer | 02/04/2014 | 173,826 |
| Marth William S | President and CEO | 02/04/2014 | 999,999 |
| RYAN UNA S | Director | 02/04/2014 | 35,003 |
| ROTH ARTHUR J | Director | 02/04/2014 | 35,003 |
| OCONNOR KEVIN | Director | 02/04/2014 | 35,003 |
| LEUNG GABRIEL | Director | 02/04/2014 | 35,003 |
| Jordan Veronica GH | Director | 02/04/2014 | 35,003 |
| D AMBRA THOMAS E PHD | Director | 02/04/2014 | 35,003 |
| Marth William S | President and CEO | 01/01/2014 | 1,000,007 |
| D AMBRA THOMAS E PHD | Director | 01/01/2014 | 1,000,007 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 12/04/2013 | 7,325 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 12/04/2013 | 27,325 |
| CABLE STUART M | 10% Owner | 12/02/2013 | 22,800 |
| Marth William S | Director | 12/03/2013 | 322,500 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 11/22/2013 | 26,565 |
| Marth William S | Director | 11/22/2013 | 231,400 |
| CABLE STUART M | 10% Owner | 11/01/2013 | 391,800 |
| CABLE STUART M | 10% Owner | 10/01/2013 | 385,500 |
| CABLE STUART M | 10% Owner | 09/13/2013 | 360,000 |
| CABLE STUART M | 10% Owner | 08/01/2013 | 375,900 |
| CABLE STUART M | 10% Owner | 07/01/2013 | 374,100 |
| CABLE STUART M | 10% Owner | 06/12/2013 | 360,000 |
| RYAN UNA S | Director | 06/05/2013 | 15,000 |
| Marth William S | Director | 06/05/2013 | 29,999 |
| ROTH ARTHUR J | Director | 06/05/2013 | 4,142 |
| OCONNOR KEVIN | Director | 06/05/2013 | 15,000 |
| Jordan Veronica GH | Director | 06/05/2013 | 15,000 |
| Marth William S | Director | 06/03/2013 | 102,300 |
| Marth William S | Director | 06/03/2013 | 102,300 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 05/29/2013 | 9,008 |
| Sargent Bruce J | Sr VP, Drug Discovery | 05/22/2013 | 21,975 |
| Sargent Bruce J | Sr VP, Drug Discovery | 05/22/2013 | 82,275 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 05/10/2013 | 12,480 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/19/2013 | 2,557 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/18/2013 | 2,555 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 03/18/2013 | 2,485 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 03/19/2013 | 1,784 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 03/12/2013 | 7,278 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/13/2013 | 9,108 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/12/2013 | 18,942 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/11/2013 | 36,265 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 03/07/2013 | 9,560 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/22/2013 | 8,049 |
| Sargent Bruce J | Sr VP, Drug Discovery | 02/22/2013 | 8,049 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 02/19/2013 | 7,890 |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | 01/31/2013 | 159,729 |
| HENDERSON LORI M | VP, general counsel | 01/31/2013 | 69,879 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 01/31/2013 | 59,900 |
| Nolan Michael M | VP, CFO and Treasurer | 01/31/2013 | 79,865 |
| Sargent Bruce J | Sr VP, Drug Discovery | 01/31/2013 | 59,900 |
| RYAN UNA S | Director | 01/31/2013 | 35,000 |
| ROTH ARTHUR J | Director | 01/31/2013 | 35,000 |
| OCONNOR KEVIN | Director | 01/31/2013 | 35,000 |
| Marth William S | Director | 01/31/2013 | 35,000 |
| LEUNG GABRIEL | Director | 01/31/2013 | 35,000 |
| Jordan Veronica GH | Director | 01/31/2013 | 35,000 |
| Marth William S | Director | 12/03/2012 | 50,000 |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | 11/15/2012 | 38,000 |
| D AMBRA CONSTANCE M | 10% Owner | 11/15/2012 | 38,000 |
| Hagen Steven R | Sr VP Pharmaceutical Dev & Mfg | 11/05/2012 | 1,306 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 08/24/2012 | 3,220 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 08/09/2012 | 9,000 |
| Sargent Bruce J | Sr VP, Drug Discovery | 06/05/2012 | 1,149 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 06/05/2012 | 1,149 |
| RYAN UNA S | Director | 06/06/2012 | 15,000 |
| ROTH ARTHUR J | Director | 06/06/2012 | 17,499 |
| OCONNOR KEVIN | Director | 06/06/2012 | 15,000 |
| Marth William S | Director | 06/06/2012 | 30,000 |
| LEUNG GABRIEL | Director | 06/06/2012 | 15,000 |
| Jordan Veronica GH | Director | 06/06/2012 | 15,000 |
| RYAN UNA S | Director | 05/22/2012 | 562 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 05/15/2012 | 7,224 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/19/2012 | 3,204 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 03/19/2012 | 2,975 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 03/06/2012 | 242 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/06/2012 | 585 |
| Sargent Bruce J | Sr VP, Drug Discovery | 02/17/2012 | 29,300 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 02/17/2012 | 29,300 |
| Frost Mark T | Chief Financial Officer | 02/17/2012 | 39,066 |
| HENDERSON LORI M | VP, general counsel | 02/17/2012 | 34,181 |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | 02/17/2012 | 78,131 |
| LEUNG GABRIEL | Director | 12/07/2011 | 9,360 |
| LEUNG GABRIEL | Director | 12/06/2011 | 9,800 |
| HENDERSON LORI M | VP, general counsel | 12/07/2011 | 14,573 |
| Frost Mark T | Chief Financial Officer | 12/01/2011 | 22,600 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 11/14/2011 | 1,001 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 11/04/2011 | 3,542 |
| D AMBRA THOMAS E PHD | Chairman, CEO & President | 06/02/2011 | 139,997 |
| Frost Mark T | Chief Financial Officer | 06/02/2011 | 69,998 |
| HENDERSON LORI M | VP, general counsel | 06/02/2011 | 61,247 |
| Sargent Bruce J | Sr VP, Drug Discovery | 06/02/2011 | 52,500 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 06/02/2011 | 52,500 |
| ANDERSON PAUL S | Director | 06/01/2011 | 14,999 |
| Jordan Veronica GH | Director | 06/01/2011 | 14,999 |
| LEUNG GABRIEL | Director | 06/01/2011 | 14,999 |
| OCONNOR KEVIN | Director | 06/01/2011 | 20,000 |
| ROTH ARTHUR J | Director | 06/01/2011 | 10,280 |
| RYAN UNA S | Director | 06/01/2011 | 14,999 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 05/06/2011 | 958 |
| Sargent Bruce J | Sr VP, Drug Discovery | 05/06/2011 | 1,147 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/18/2011 | 3,607 |
| Sargent Bruce J | Sr VP, Drug Discovery | 03/07/2011 | 941 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 03/18/2011 | 2,579 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 03/07/2011 | 388 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 12/06/2010 | 10,400 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 11/14/2010 | 5,118 |
| Hagen Steven R | VP Pharmaceutical Dev & Mfg | 11/10/2010 | 2,162 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...